Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope
Manuscript Number:
16-0695R3
Author(s):
Oskar Adolfsson, Peter Borghgraef, Natalia Crespo-Biel, Herman Devijver, Valérie Gafner, David T. Hickman, Andreas Muhs, Andrea Pfeifer, Maria Pihlgren, Kasia Piorkowska, Clara Theunis, Fred van Leuven
Disclosures
Oskar Adolfsson
Equity:
I have equity ownership in AC Immune SA.
Sponsors:
I am employed as a Scientist at AC Immune SA.
Patents/Royalties
I am listed as an inventor on two patent applications: WO2012/045882 and WO2013/050567. As an inventor, I did not receive any personal financial income in respect to these two patent applications.
Peter Borghgraef
Nothing to Disclose
Natalia Crespo-Biel
Nothing to Disclose
Herman Devijver
Nothing to Disclose
Valérie Gafner
Nothing to Disclose
David T. Hickman
Equity:
I have shares in AC Immune SA
Sponsors:
Full time employee at AC Immune SA
Andreas Muhs
Equity:
I am shareholder of AC Immune.
Sponsors:
Full time employment
Andrea Pfeifer
Equity:
Conflict of interest disclosure:
AP is an employee of AC Immune SA, and has equity ownership in the company. .
Sponsors:
CEO
Patents/Royalties
AP is listed as inventor on two patent applications: WO2012/045882 and WO2013/050567. The inventor did not receive any personal financial income in respect to the two patent applications.
Maria Pihlgren
Equity:
I have equity ownership in AC Immune SA.
Sponsors:
I am an employee of AC Immune SA.
Patents/Royalties
I am an inventor on two patent applications: WO2012/045882 and WO2013/050567. I did not receive any personal financial income in respect to these two patent applications.
Kasia Piorkowska
Equity:
I hold shares of AC Immune SA
Sponsors:
I am employed by AC Immune SA as a scientist.
Clara Theunis
Nothing to Disclose
Fred van Leuven
Equity:
EQUITY OWNERSHIP IN ACIMMUNE
Patents/Royalties
INVENTOR ON PATENT APPLICATIONS WO2012/045882 and WO2013/050567